ProKidney Corp. (Nasdaq: PROK) (“ProKidney” or the “Company"), a leading late clinical-stage cellular therapeutics company ...

The US Food and Drug Administration (FDA) has issued a complete response letter (CRL) for Unicycive Therapeutics’ New Drug ...

Breast cancer treatment might offer protection against Alzheimer's disease, with a study of 70,000 survivors showing lower ...

Note that some links may require registration or subscription. A 35-year-old gastroenterologist pleaded guilty to sexually ...

No need to count carbohydrates with these nutritious foods and drinks — they contain less than 5 grams of carbs per serving.

GLP-1 drugs currently being tested in China target complications associated with obesity such as heart disease, fatty liver ...

Breaking down what patients should know about each FDA therapeutic approval from June 2025 across various oncology ...

Once-weekly cagrilintide–semaglutide combination therapy produced unprecedented weight reductions in adults with overweight or obesity, with 60% achieving ≥20% loss and strong cardiometabolic benefits ...

Dysregulation of the alternative complement pathway, hallmarked by isolated reduction of the serum C3 fraction, is now recognized as an additional feature of lupus nephritis. Persistent, isolated low ...

Test Boost Max enters 2025 as a leading plant-based testosterone supplement, offering men a science-backed, non-synthetic ...